Waksman Institute, Rutgers University
@Waksman_Inst
Followers
2K
Following
888
Media
171
Statuses
651
Interdisciplinary research institute focused on microbiology, developmental biology, cell biology, structural biology, genetics, and genomics. Founded in 1954.
Piscataway, NJ
Joined January 2021
RT @AMRActionFund: "If selling antibiotics loses money, no one will invest.”. CEO Henry Skinner recently discussed with @swissinfo_en why….
swissinfo.ch
Switzerland risks stalling global antibiotic innovation amid rising resistance.
0
3
0
RT @R_H_Ebright: "A UK government-funded study shows that without concerted action, increased rates of antimicrobial resistance could lead….
theguardian.com
Exclusive: Research on burden of antibiotic resistance for 122 countries predicts dire economic and health outcomes
0
12
0
RT @R_H_Ebright: "Most people don’t understand how important antibiotics are to cancer care. My entire ability to treat. cancer is predica….
statnews.com
Oncologists must join the global fight against microbial resistance.
0
34
0
RT @R_H_Ebright: "[A]ntimicrobial resistance. contributes to 4.5 million deaths annually". "[V]ery few new antibiotics are in development….
innovationnewsnetwork.com
Henry Skinner of the AMR Action Fund, illustrates the true picture of the threat of AMR and work to change the way society values antibiotics.
0
13
0
RT @R_H_Ebright: Antibacterial agents: soluble salts and aqueous formulations of pyronins. US Patent application 20250115594 (filed 04/10/2….
0
13
0
European patent issued to Ebright lab at Waksman Institute.
Antibacterial agents: O-alkyl-deuterated pyronins. European Patent EP3752143. (issued 04/09/2025).
0
0
2
Patent application from Ebright lab at Waksman Institute (03/13/2025).
Dual-targeted RNA polymerase inhibitors: conjugates of benzoxazino- and spiro-rifamycins with Nα-aroyl- N-aryl-phenylalaninamides. US Patent Application 20250082761. (Novel compounds effective against MDR and XDR M. tuberculosis; highly active in mice.).
0
0
1
RT @R_H_Ebright: "[A]ntimicrobial resistance…is one of the major global threats to human health…[T]he current clinical development pipeline….
0
3
0
RT @R_H_Ebright: "Here, we communicate…characterization of MtbRNAP elongation and its inhibition by…N(α)-aroyl-N-aryl-phenylalaninamide…, s….
biorxiv.org
The Mycobacterium tuberculosis RNA polymerase (MtbRNAP) is the target of the first-line anti-tuberculosis inhibitor rifampin, however, the emergence of rifampin resistance necessitates the developm...
0
7
0
RT @R_H_Ebright: With a broken market for antibacterial drugs, each ***success*** in developing a new antibacterial drug effective against….
0
9
0
RT @R_H_Ebright: Biotechs ‘cry for help’ to fix antibiotics market failure. Developers are reluctantly shelving promising drugs due to mark….
politico.eu
Developers are reluctantly shelving promising drugs due to market failure.
0
10
0
RT @R_H_Ebright: Antibacterial agents: soluble salts and aqueous formulations of pyronins. US Patent 12,209,082 (issued 01/28/2025).https:/….
0
6
0
RT @R_H_Ebright: Five years ago today, the emerging pandemic that would go on to kill 20+ million and cost $25+ trillion became unmissable.….
0
4
0
RT @R_H_Ebright: Five years ago today, the emerging pandemic that would go on to kill 20+ million and cost $25+ trillion became unmissable.….
0
54
0
RT @R_H_Ebright: Five years ago today, the emerging pandemic that would go on to kill 20+ million and cost $25+ trillion became unmissable.….
0
9
0
RT @R_H_Ebright: @harishseshadri2 @hkakeya In the US, research on Ebola virus research is performed in downtown Boston and on the Galveston….
0
7
0
RT @pricklyresearch: 🧵 Biosafety Flashback '09. The University of Texas Medical Branch (UTMB) Commits Perjury while Trying to Shut Down #FO….
0
14
0
RT @R_H_Ebright: '[W]e identified 9 highly drug-resistant strains from 4 countries that carried resistance mutations to [rifampin, isoniazi….
0
6
0
RT @R_H_Ebright: "Recently…WHO endorsed new regimens for the treatment of MDR-TB that rely on…bedaquiline, pretomanid, and linezolid with…m….
nejm.org
Whole-genome sequencing was used to show that resistance to newer antituberculosis drugs is present in at least 27 countries and that up to a quarter of this resistance may be due to person-to-...
0
4
0
RT @R_H_Ebright: "[R]esistance to shorter and less toxic drug regimens for multidrug-resistant tuberculosis (MDR-TB) is emerging and spread….
cidrap.umn.edu
0
6
0